an increasing trendp < 0.001
KM analyses also revealed an increasing trend of first-line cART modification with a lower pre-cART CD4+ T-cell count (< 350 μL) ( p < 0.001).
KM analyses also revealed an increasing trend of first-line cART modification with a lower pre-cART CD4+ T-cell count (< 350 μL) ( p < 0.001).
Data from Australia showed a trend to fewer treatment modifications in recent years and demonstrated a stable rate of first-line treatment modifications, comparable to other cohorts [ 8 ].